Treatment of Adult Soft Tissue Sarcomas: An Overview

被引:0
作者
Samia Arifi
Rhizlan Belbaraka
Rabie Rahhali
Nabil Ismaili
机构
[1] Sidi Mohamed Ben Abdellah University,Department of Medical Oncology, Hassan II University Hospital, Medical School
[2] Mohammed VI University Hospital,Department of Medical Oncology
[3] Regional Center of Oncology,Department of Medical Oncology
来源
Rare Cancers and Therapy | 2015年 / 3卷 / 1-2期
关键词
Chemotherapy; Radiotherapy; Soft tissue sarcoma; Surgery; Targeted therapy;
D O I
10.1007/s40487-015-0011-x
中图分类号
学科分类号
摘要
Sarcomas are uncommon malignancies accounting for about 1% of all adult malignancies. Sarcomas are a heterogeneous group of tumors which includes more than 100 different subtypes. Surgery is the mainstay therapy for localized disease. In selected patients the combination of surgery with radiotherapy achieves better local control and offers the best chance of cure. Systemic treatment including cytotoxic chemotherapy or targeted therapies remains the mainstay therapy for most patients with advanced disease. There are a wide variety of clinical situations, such that an individualized treatment plan must be defined by a multidisciplinary tumor board. Treatment decisions should take into consideration the histology, site of disease, stage, performance status, treatment goals, and the patient’s wishes. The management of patients should be carried out in a center with expertise in the treatment of sarcomas for optimal outcome. This review will cover the different treatment modalities of adult soft tissue sarcomas.
引用
收藏
页码:69 / 87
页数:18
相关论文
共 313 条
[51]  
Baldini EH(2009)Effectiveness and morbidity associated with reirradiation in conservative salvage management of recurrent soft-tissue sarcoma Int J Radiat Oncol Biol Phys. 73 267-1104
[52]  
Gildgerg J(1999)Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field Cancer J Sci Am 5 26-1733
[53]  
Jenner C(2005)Isolated limb perfusions with tumor necrosis factor and melphalan for locally recurrent soft tissue sarcoma in previously irradiated limbs Ann Surg Oncol 12 406-840
[54]  
Pisters PW(2011)Trends in survival for patients with metastatic soft-tissue sarcoma Cancer 117 1049-undefined
[55]  
Pollock RE(2014)Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatisoft-tissue sarcoma: a randomised controlled phase 3 trial Lancet Oncol 15 415-undefined
[56]  
Lewis VO(2003)Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy Eur J Cancer 39 64-undefined
[57]  
Cahlon O(2009)Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival Ann Thorac Surg 88 877-undefined
[58]  
Brennan MF(1999)Pulmonary metatases from soft tissue sarcoma: analysis of patterns of disease and postmetastases survival Ann Surg 229 602-undefined
[59]  
Jia X(2000)Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline Sarcoma 4 103-undefined
[60]  
Qin LX(2001)Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group Eur J Cancer 37 870-undefined